Cargando…
Is Infantile Hemangioma a Neuroendocrine Tumor?
Infantile hemangioma (IH) is the most common infantile tumor, affecting 5–10% of newborns. Propranolol, a nonselective β-adrenergic receptor (ADRB) antagonist, is currently the first-line treatment for severe IH; however, both its mechanism of action and its main cellular target remain poorly unders...
Autores principales: | Kaulanjan-Checkmodine, Priscilla, Oucherif, Sandra, Prey, Sorilla, Gontier, Etienne, Lacomme, Sabrina, Loot, Maya, Miljkovic-Licina, Marijana, Cario, Muriel, Léauté-Labrèze, Christine, Taieb, Alain, Moisan, François, Rezvani, Hamid Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104933/ https://www.ncbi.nlm.nih.gov/pubmed/35563552 http://dx.doi.org/10.3390/ijms23095140 |
Ejemplares similares
-
Congenital haemangiomas: a single-centre retrospective review
por: Braun, Victoire, et al.
Publicado: (2020) -
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations
por: Del Frari, Laurence, et al.
Publicado: (2018) -
Medical management of vascular anomalies of the head and neck
por: Léauté‐Labrèze, Christine
Publicado: (2022) -
Urticaire de l’enfant
por: Boralevi, F., et al.
Publicado: (2020) -
Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review
por: DIOCIAIUTI, Andrea, et al.
Publicado: (2020)